Jeffrey Humphrey - Dec 15, 2021 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
/s/ Andrew Gengos, Attorney-in-Fact
Stock symbol
CYT
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
4
Date filed
12/16/2021, 03:35 PM
Previous filing
Oct 4, 2021
Next filing
Feb 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Award $0 +28.3K $0.00 28.3K Dec 15, 2021 Common Stock 28.3K $10.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of December 15, 2021, subject to the Reporting Person's continued service to the board of directors of the Issuer through the applicable vesting date.